mHealth Spot

SmartenFit is a mobile app made for people looking for a simplified way to monitor their nutritional intake, exercise, and goal attainment.

The Menlo Park-based company has raised just over $14 million to date for its robot-operated biolab, and is all set to move into drug-screening tests.

It's not really the same thing as 23andMe's original offering which screened for 254 diseases, but it's an important step in the right direction.

The two parties are teaming-up to form Vivre Health, a strategic alliance to bring healthcare to the home through telehealth and home health solutions.

The company will use Melon's tech in its Smart Helmet to allow users to monitor vital signs like heart rate, temperature, stress level, attention and fatigue.

Powered by Techstars, it is a three-month, mentor-driven program for 10 participating startups which will be announced on March 9th.

Initially though, the App Exchange service will focus on Epic's existing customer based, with consumer-focused apps coming at a later date.

The partnership follows the successful pilot program completion with Aetna employees who had, or were at risk for, Metabolic Syndrome.

Telcare will deliver remote monitoring and engagement services for select diabetic beneficiaries enrolled under the Texas Medicaid STAR+PLUS Program.

The company will use the funds to complete the pilots it's currently running and convert them to commercial contracts, as well as for general operations.